Levenfeld Pearlstein, LLC
Method using an Y1 receptor activator for treating an anticancer agent-induced nephrotoxic injury
There is provided a method for treating or reducing an anticancer agent-induced nephrotoxic injury, the method comprising the step of administering a Y1 receptor activator in an amount effective to treat or reduce the anticancer agent-induced nephrotoxic injury in a subject. Further, there is provided a method for screening an agent for treating or reducing an anticancer agent-induced nephrotoxic injury, the method comprising (a) applying a candidate material to a test sample of renal tissues or cells; and (b) identifying a Y1 receptor signaling in the test sample of renal tissues or cells.
KYUNGPOOK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION
G G A A G G G
G01N G01N A61K A61K G01N G01N G01N
additional additional inventional inventional additional inventional inventional
Hee Kyung Jae Sung Min Hee
Jin Bae Park